Nephrology

An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis

Condition:   Lupus Nephritis
Interventions:   Drug: BMS-986165;   Drug: Placebo
Sponsor:   Bristol-Myers Squibb
Recruiting
ClinicalTrials.gov: Nephrology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 4, 2019Comments OffBackground | BMS986165 | Effectiveness | Evaluate | Investigational | Lupus | Nephritis | Participants | Safety | Study | Treatment
A Trial of Bardoxolone Methyl in Patients With ADPKD – FALCON

Conditions:   Autosomal Dominant Polycystic Kidney;   ADPKD
Interventions:   Drug: Bardoxolone methyl oral capsule;   Drug: Placebo oral capsule
Sponsor:   Reata Pharmaceuticals, Inc.
Recruiting
ClinicalTrials.gov: Nephrology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 3, 2019Comments OffADPKD | Bardoxolone | FALCON | Methyl | Patients | Trial
A Study to Identify Participants With Advanced Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations

Conditions:   Urothelial Cancer;   Receptors, Fibroblast Growth Factor
Intervention:   Other: Archival Tumor Tissue Sample
Sponsor:   Janssen Research & Development, LLC
Not yet recruiting
ClinicalTrials.gov: Nephrology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 24, 2019Comments OffAberrations | Advanced | Cancer | Factor | Fibroblast | Gene | Growth | Identify | Participants | Receptor | Study | Urothelial
Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition

Conditions:   Chronic Kidney Diseases;   Inflammation
Intervention:   Biological: Ziltivekimab
Sponsor:   Corvidia Therapeutics
Not yet recruiting
ClinicalTrials.gov: Nephrology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 21, 2019Comments OffAdvanced | Antibody | Chronic | Disease | Evaluate | Inflammation | Inhibition | Mediated | Patients | Reduction | Renal | Trial | Utilizing
Belimumab With Rituximab for Primary Membranous Nephropathy

Conditions:   Membranous Nephropathy;   MN
Interventions:   Drug: Belimumab;   Drug: Placebo for Belimumab;   Drug: Rituximab
Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Immune Tolerance Network (ITN)
Not yet recruiting
ClinicalTrials.gov: Nephrology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 14, 2019Comments OffBelimumab | Membranous | Nephropathy | Primary | Rituximab
Be-HealthY: Behavioral Risk Factors for Poor Vascular Health in Youth

Conditions:   Prehypertension;   Hypertension;   Overweight and Obesity;   Elevated Blood Pressure;   Endothelial Dysfunction;   Vascular Stiffness;   Sleep
Interventions:   Diagnostic Test: Cardiovascular Assessments;   Diagnostic Test: Actigraphy;   Diagnostic Test: Laboratory assessments
Sponsors:   Johns Hopkins University;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
ClinicalTrials.gov: Nephrology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 1, 2019Comments OffBehavioral | BeHealthY | Factors | Health | Poor | Risk | Vascular | Youth